Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 32 Records) |
Query Trace: Abnormalities and PTEN[original query] |
---|
A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry 2010 Apr 81 (4): 391-5. Nishioka Kenya, Kefi Mounir, Jasinska-Myga Barbara, Wider Christian, Vilariño-Güell Carles, Ross Owen A, Heckman Michael G, Middleton Lefkos T, Ishihara-Paul Lianna, Gibson Rachel A, Amouri Rim, Ben Yahmed Samia, Ben Sassi Samia, Zouari Mourad, El Euch Ghada, Farrer Matthew J, Hentati Fayc |
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood 2009 Jul 114 (3): 647-50. Gutierrez Alejandro, Sanda Takaomi, Grebliunaite Ruta, Carracedo Arkaitz, Salmena Leonardo, Ahn Yebin, Dahlberg Suzanne, Neuberg Donna, Moreau Lisa A, Winter Stuart S, Larson Richard, Zhang Jianhua, Protopopov Alexei, Chin Lynda, Pandolfi Pier Paolo, Silverman Lewis B, Hunger Stephen P, Sallan Stephen E, Look A Thom |
Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism research : official journal of the International Society for Autism Research 2010 Jun 3 (3): 137-41. McBride Kim L, Varga Elizabeth A, Pastore Matthew T, Prior Thomas W, Manickam Kandamurugu, Atkin Joan F, Herman Gail |
Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia. BMC cancer 2012 12 (1): 9. Mansur Marcela Braga, Hassan Rocio, Barbosa Thayana C, Splendore Alessandra, Jotta Patricia Y, Yunes José Andrés, Wiemels Joseph L, Pombo-de-Oliveira Maria |
Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosis. Pathology 2013 Oct 45 (6): 559-66. Stewart Colin J R, Walsh Michael D, Budgeon Charley A, Crook Maxine L, Buchanan Daniel |
Biochemical screening and PTEN mutation analysis in individuals with autism spectrum disorders and macrocephaly. European journal of human genetics : EJHG 2014 Feb 22 (2): 273-6. Hobert Judith A, Embacher Rebecca, Mester Jessica L, Frazier Thomas W, Eng Char |
Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Dec 31 (34): 4333-42. Trinquand Amélie, Tanguy-Schmidt Aline, Ben Abdelali Raouf, Lambert Jérôme, Beldjord Kheira, Lengliné Etienne, De Gunzburg Noémie, Payet-Bornet Dominique, Lhermitte Ludovic, Mossafa Hossein, Lhéritier Véronique, Bond Jonathan, Huguet Françoise, Buzyn Agnès, Leguay Thibaud, Cahn Jean-Yves, Thomas Xavier, Chalandon Yves, Delannoy André, Bonmati Caroline, Maury Sebastien, Nadel Bertrand, Macintyre Elizabeth, Ifrah Norbert, Dombret Hervé, Asnafi Vah |
The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL. Genes, chromosomes & cancer 2013 Jan . Grossmann V, Haferlach C, Weissmann S, Roller A, Schindela S, Poetzinger F, Stadler K, Bellos F, Kern W, Haferlach T, Schnittger S, Kohlmann A |
Initial experience with genomic profiling of heavily pretreated breast cancers. Annals of surgical oncology 2014 Oct 21 (10): 3216-22. Staren Edgar D, Braun Donald, Tan Bradford, Gupta Digant, Kim Seungchan, Kramer Kim, Markman Maur |
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood 2014 Jun 123 (24): 3739-49. Beldjord Kheira, Chevret Sylvie, Asnafi Vahid, Huguet Françoise, Boulland Marie-Laure, Leguay Thibaut, Thomas Xavier, Cayuela Jean-Michel, Grardel Nathalie, Chalandon Yves, Boissel Nicolas, Schaefer Beat, Delabesse Eric, Cavé Hélène, Chevallier Patrice, Buzyn Agnès, Fest Thierry, Reman Oumedaly, Vernant Jean-Paul, Lhéritier Véronique, Béné Marie C, Lafage Marina, Macintyre Elizabeth, Ifrah Norbert, Dombret Hervé, |
Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors. Cell reports 2014 Jan 6 (2): 377-87. Janku Filip, Hong David S, Fu Siqing, Piha-Paul Sarina A, Naing Aung, Falchook Gerald S, Tsimberidou Apostolia M, Stepanek Vanda M, Moulder Stacy L, Lee J Jack, Luthra Rajyalakshmi, Zinner Ralph G, Broaddus Russell R, Wheler Jennifer J, Kurzrock Razel |
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial. Leukemia 2015 Jul . Jenkinson S, Kirkwood A A, Goulden N, Vora A, Linch D C, Gale R |
Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors. PloS one 2015 10 (6): e0124711. Bellmunt Joaquim, Werner Lillian, Leow Jeffrey J, Mullane Stephanie A, Fay André P, Riester Markus, Van Hummelen Paul, Taplin Mary-Ellen, Choueiri Toni K, Van Allen Eliezer, Rosenberg Jonath |
Atypical Polypoid Adenomyoma of the Uterus: An Immunohistochemical and Molecular Study of 21 Cases. The American journal of surgical pathology 2015 Aug 39 (8): 1148-55. N?mejcová Kristýna, Kenny Sarah L, Laco Jan, Škapa Petr, Stan?k Libor, Zikán Michal, Kleiblová Petra, McCluggage W Glenn, Dundr Pav |
Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women. PloS one 2015 10 (3): e0120511. Deng Ling, Chen Jie, Zhong Xiao Rong, Luo Ting, Wang Yan Ping, Huang Hui Fen, Yin Li-Juan, Qiu Yan, Bu Hong, Lv Qing, Zheng Ho |
Targeted exome sequencing profiles genetic alterations in leiomyosarcoma. Genes, chromosomes & cancer 2015 Nov . Agaram Narasimhan P, Zhang Lei, LeLoarer Francois, Silk Tarik, Sung Yun-Shao, Scott Sasinya N, Kuk Deborah, Qin Li-Xuan, Berger Michael F, Antonescu Cristina R, Singer Samu |
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer. PloS one 2015 10 (11): e0141763. Cossu-Rocca Paolo, Orrù Sandra, Muroni Maria Rosaria, Sanges Francesca, Sotgiu Giovanni, Ena Sara, Pira Giovanna, Murgia Luciano, Manca Alessandra, Uras Maria Gabriela, Sarobba Maria Giuseppina, Urru Silvana, De Miglio Maria Rosar |
A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer. Gynecologic oncology 2016 Apr 141 (1): 108-12. Penson R T, Sales E, Sullivan L, Borger D R, Krasner C N, Goodman A K, Del Carmen M G, Growdon W B, Schorge J O, Boruta D M, Castro C M, Dizon D S, Birrer M |
ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast. Oncotarget 2016 Nov . Ping Zheng, Siegal Gene P, Harada Shuko, Eltoum Isam-Eldin, Youssef Mariam, Shen Tiansheng, He Jianbo, Huang Yingjie, Chen Dongquan, Li Yiping, Bland Kirby I, Chang Helena R, Shen Dej |
Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia. Leukemia 2017 12 31 (12): 2594-2600. Tesio M, Trinquand A, Ballerini P, Hypolite G, Lhermitte L, Petit A, Ifrah N, Baruchel A, Dombret H, Macintyre E, Asnafi |
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma. Neoplasia (New York, N.Y.) 2018 May 20 (6): 574-593. Wang Xiaoxiao, Cao Xin, Sun Ruifang, Tang Charlene, Tzankov Alexandar, Zhang Jun, Manyam Ganiraju C, Xiao Min, Miao Yi, Jabbar Kausar, Tan Xiaohong, Pang Yuyang, Visco Carlo, Xie Yan, Dybkaer Karen, Chiu April, Orazi Attilio, Zu Youli, Bhagat Govind, Richards Kristy L, Hsi Eric D, Choi William W L, van Krieken J Han, Huh Jooryung, Ponzoni Maurilio, Ferreri Andrés J M, Møller Michael B, Parsons Ben M, Winter Jane N, Piris Miguel A, Li Shaoying, Miranda Roberto N, Medeiros L Jeffrey, Li Yong, Xu-Monette Zijun Y, Young Ken |
Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy. JAMA oncology 2018 May . Lucchesi Carlo, Khalifa Emmanuel, Laizet Yec'han, Soubeyran Isabelle, Mathoulin-Pelissier Simone, Chomienne Christine, Italiano Antoi |
PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma. Oral oncology 2019 3 91 69-78. Eze Nnamdi, Lee Ju-Whei, Yang Dong-Hua, Zhu Fang, Neumeister Veronique, Sandoval-Schaefer Teresa, Mehra Ranee, Ridge John A, Forastiere Arlene, Chung Christine H, Burtness Barba |
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making. JCO precision oncology 2019 10 1 . Tao Derrick L, Bailey Shawna, Beer Tomasz M, Foss Erik, Beckett Brooke, Fung Alice, Foster Bryan R, Guimaraes Alexander, Cetnar Jeremy P, Graff Julie N, Eilers Kristine M, Small Eric J, Corless Christopher L, Thomas George V, Alumkal Joshi |
Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression. Blood research 2020 8 55 (3): 131-138. Srinivasan Vishrut K, Naseem Shano, Varma Neelam, Lad Deepesh P, Malhotra Pank |
Cerebral MRI and Clinical Findings in Children with PTEN Hamartoma Tumor Syndrome: Can Cerebral MRI Scan Help to Establish an Earlier Diagnosis of PHTS in Children? Cells 2020 7 9 (7): . Plamper Michaela, Born Mark, Gohlke Bettina, Schreiner Felix, Schulte Sandra, Splittstößer Vera, Woelfle Joach |
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer. BMC medicine 2022 3 20 (1): 112. Mak Blossom, Lin Hui-Ming, Kwan Edmond M, Fettke Heidi, Tran Ben, Davis Ian D, Mahon Kate, Stockler Martin R, Briscoe Karen, Marx Gavin, Zhang Alison, Crumbaker Megan, Tan Winston, Huynh Kevin, Meikle Thomas G, Mellett Natalie A, Hoy Andrew J, Du Pan, Yu Jianjun, Jia Shidong, Joshua Anthony M, Waugh David J, Butler Lisa M, Kohli Manish, Meikle Peter J, Azad Arun A, Horvath Lisa |
Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy. Cancers 2022 Jul 14 (14): . Matsumae Takayuki, Kodama Takahiro, Myojin Yuta, Maesaka Kazuki, Sakamori Ryotaro, Takuwa Ayako, Oku Keiko, Motooka Daisuke, Sawai Yoshiyuki, Oshita Masahide, Nakabori Tasuku, Ohkawa Kazuyoshi, Miyazaki Masanori, Tanaka Satoshi, Mita Eiji, Tawara Seiichi, Yakushijin Takayuki, Nozaki Yasutoshi, Hagiwara Hideki, Tahata Yuki, Yamada Ryoko, Hikita Hayato, Tatsumi Tomohide, Takehara Tets |
Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer. Frontiers in oncology 2024 4 14 1381134. Michael C Repka, Tamir Sholklapper, Alan L Zwart, Malika Danner, Marilyn Ayoob, Thomas Yung, Siyuan Lei, Brian T Collins, Deepak Kumar, Simeng Suy, Ryan A Hankins, Amar U Kishan, Sean P Colli |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: